about
Advances in chest drain management in thoracic diseaseLeft ventricular assist device and drug therapy for the reversal of heart failureThe expanded role of extracellular matrix patch in malignant and non-malignant chest wall reconstruction in thoracic surgery.The left ventricular outflow in hypertrophic cardiomyopathy: from structure to function.Expression of follistatin-related genes is altered in heart failure.Cardiac iodine-123 metaiodobenzylguanidine imaging predicts ventricular arrhythmia in heart failure patients receiving an implantable cardioverter-defibrillator for primary prevention.A rare case of occult splenic rupture after left pneumonectomy.Novel technique in managing bronchobiliary fistula in adults: Endobronchial embolization using silicone spigots in 2 cases.The effect of long-term left ventricular assist device support on myocardial sympathetic activity in patients with non-ischaemic dilated cardiomyopathy.Totally Endoscopic (VATS) First Rib Resection for Thoracic Outlet Syndrome.Hemodynamic and echocardiographic responses to acute interruption of left ventricular assist device support: relevance to assessment of myocardial recovery.Midterm experience with the Jarvik 2000 axial flow left ventricular assist device.Changes in sarcomeric and non-sarcomeric cytoskeletal proteins and focal adhesion molecules during clinical myocardial recovery after left ventricular assist device support.Bridge to transplantation with a left ventricular assist device for systemic ventricular failure after Mustard procedure.A quantitative gene expression profile of matrix metalloproteinases (MMPS) and their inhibitors (TIMPS) in the myocardium of patients with deteriorating heart failure requiring left ventricular assist device support.Molecular signature of recovery following combination left ventricular assist device (LVAD) support and pharmacologic therapy.Acinetobacter mediastinitis in a heart transplant patient.Long-term outcomes after autograft versus homograft aortic root replacement in adults with aortic valve disease: a randomised controlled trial.Expression of extracellular matrix genes during myocardial recovery from heart failure after left ventricular assist device support.Lung herniation after uniportal video-assisted thoracic surgery lobectomy presenting with subcutaneous surgical emphysema.Correlation between vascular responsivensss and expression of novel transcripts of the ETA-receptor in human vascular tissueSustained myocardial recovery 5 years after in situ disconnection of a Jarvik 2000 deviceReversal of severe heart failure with a continuous-flow left ventricular assist device and pharmacological therapy: a prospective studyLong-term outcomes of patients bridged to recovery versus patients bridged to transplantationComparison of cardiac power output and exercise performance in patients with left ventricular assist devices, explanted (recovered) patients, and those with moderate to severe heart failureRelationship between peak cardiac pumping capability and selected exercise-derived prognostic indicators in patients treated with left ventricular assist devicesThe impact of acute reduction of continuous-flow left ventricular assist device support on cardiac and exercise performanceEchocardiographic assessment of flow across continuous-flow ventricular assist devices at low speedsCardiovascular autonomic control in patients undergoing left ventricular assist device (LVAD) support and pharmacologic therapy
P50
Q26768415-EE578AF4-E409-4920-9C5B-B4A2EB43FADDQ28271792-8695B650-ED2A-40A8-889C-94D4A958791CQ37594975-02B836ED-7C23-4E76-9FB4-9336C6FAD7A5Q37766186-E1D52D9C-4CE6-42BB-957E-846B6910FE28Q38289371-413B7B61-5CB9-488E-8B73-B9AC0522AD97Q39567151-569F8CFD-9EA6-49BB-9A8B-7B0696E8EA96Q42782856-0349C3BE-37AB-4508-9D78-66B66157AA3FQ43095517-A6712EFA-8ABC-4ECE-8555-7DEAED454451Q44702881-A576DA8A-F19C-4FCD-BD59-426025236998Q47996113-0560B1E8-279E-407C-93D4-FF59278B8D4DQ50895727-7C68646A-04C1-43BE-B567-20E97AB2B0E6Q50967599-0D8E3E7D-B907-4BAB-BDD2-6EBFF905A60DQ51052997-560242C1-DC2A-4461-903B-7A5D45900D0EQ51092091-96F583C3-6CF9-4260-A69D-BCC1EBEE2CFBQ51092824-B453140D-5691-4BD3-AE31-DE54A0E5020CQ51099907-9B1903D8-3D13-4858-8831-3138CE6A63B6Q51156885-02E5466C-6EE9-4777-93E6-B480A381DE4BQ51549040-6F6BBEB4-24D6-41AE-B610-58D57973EF85Q51833940-2594153E-7E66-44A8-A25E-CE1CE3BF70F6Q52836749-DD464228-A218-47C9-BE7A-A3B9E0DA42B1Q61908326-C70389BC-A38C-4021-9C62-9AB358561327Q83145525-CA81F2AA-A1DD-4852-B961-2941BD87849AQ83224125-76986720-E491-4FF3-A4F0-10E02C18249EQ83874931-1EA4DC44-FEED-4304-A8BA-1D60594683D1Q84384864-59354DC5-5525-4D05-9EAB-7F2A94F909ECQ84480858-B26B3123-E86F-4B2F-9F29-0BB38BC2E6BBQ84579489-7436B1A3-82AD-4A21-B4FE-FD8007BDC5E7Q84676233-C9D9A321-E6B2-47DF-BE81-9E8BCD480C2CQ87164460-879CE9EC-318A-498F-8CDF-598F79022E6E
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Robert S George
@ast
Robert S George
@en
Robert S George
@es
Robert S George
@nl
Robert S George
@sl
type
label
Robert S George
@ast
Robert S George
@en
Robert S George
@es
Robert S George
@nl
Robert S George
@sl
prefLabel
Robert S George
@ast
Robert S George
@en
Robert S George
@es
Robert S George
@nl
Robert S George
@sl
P106
P21
P31
P496
0000-0002-1248-8299